Also, McCarron K. F. et al. [89] reported that combining CD79b determination alongside CD5 was of huge importance in resolving misclassification, making both essential to use in testing panels for CLL. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.